Page 6 - Lexaria Bioscience News Today

Lexaria Bioscience Corp. (NASDAQ:LEXX – Get Free Report) was the target of a large increase in short interest during the month of September. As of September 30th, there was short interest totalling 422,900 shares, an increase of 14.5% from the September 15th total of 369,200 shares. Approximately 5.8% of the shares of the company are […]

Shares of Lexaria Bioscience Corp. (OTCMKTS:LXRP – Get Free Report) crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.22 and traded as high as $0.25. Lexaria Bioscience shares last traded at $0.22, with a volume of 2,151,500 shares. Lexaria Bioscience Stock Performance The firm […]

Drug Delivery Platform Innovator With Multiple Mainstream Applications Investor Presentation Q3 2023 ...

LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...

Lexaria Provides Update on Investigational New Drug Application Progress ...

Lexarias DehydraTECH-Nicotine Faster than ZYN and on!

Maxim Group initiated coverage on shares of Lexaria Bioscience (NASDAQ:LEXX – Free Report) in a research report released on Friday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $2.00 price objective on the stock. Lexaria Bioscience Stock Performance NASDAQ LEXX opened at $0.86 on Friday. Lexaria Bioscience has a one year low […]

LEXX | Complete Lexaria Bioscience Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Lexaria Bioscience Corp. (OTCMKTS:LXRP – Get Free Report)’s stock price passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.22 and traded as high as $0.25. Lexaria Bioscience shares last traded at $0.22, with a volume of 2,151,500 shares changing hands. Lexaria Bioscience Price Performance […]

Lexaria Granted Strategically Important New US Patent For DehydraTECH-Nicotine ...